About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...
Digital GMP expectations are increasing, driven by Annex 11 and Annex 22, necessitating robust lifecycle management, data ...
TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...
TipRanks on MSN
Akari Therapeutics initiates GMP manufacturing of AKTX-101
Akari Therapeutics (AKTX) announced the initiation of GMP manufacturing activities to support the development of AKTX-101, the Company’s lead ADC ...
G-protein coupled receptors (GPCRs) are proteins triggered by ligands (protein-binding chemicals) from outside cells to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback